Sunday November 22 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Lumera Corporation

Lumera develops proprietary polymer materials and products based on these materials for a broad range of applications. We engineer polymer materials at the molecular level - commonly referred to as nanotechnology - to optimize their electrical, optical and/or surface properties. We use these materials to improve the design, performance and functionality of devices used primarily in bioscience and in communications and computing.Lumera has developed a strong proprietary position based on a combination of our patents, trade secrets and proprietary methods relating to the design and characterization of polymer materials, methods of polymer synthesis, production of polymers in commercial quantities, as well as device design, characterization, fabrication, testing and packaging technology for polymer products. This position is strengthened by strategic relationships with universities, government agencies and corporate partners, which provide us exclusive access to key technology relating to materials and manufacturing methods.


Contact Details:
19910 N. Creek Pkwy, suite 100
Bothell
Washington
98011
United States of America
Tel:425.415.6900
Fax:425.398.6599
Email:info@lumera.com
WWW:

www.lumera.com/




Loading...

Recent Publications by Lumera Corporation:

Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies.
Surface plasmon resonance (SPR) biosensors have enabled a wide range of...
6th October, 2006
Lumera Corporation, Bothell, WA 98011, USA. Curr Opin Biotechnol. 2006 Aug;17(4):400-5. Epub 2006 Jul 11.
DOI Direct Link

Press Releases on Lumera Corporation:

BioPortfolio Logo
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update 15th June, 2009 Helix BioPharma Corp.
AURORA, Ontario, June 15 /PRNewswire/ -- Helix BioPharma Corp. ("Helix" or the "Company"), (TSX, FSE: "HBP") today announced its product development progress, quarterly

BioNews Results for Lumera Corporation:

Carl Zeiss Meditec introduces new treatment workflow, data management systems
Ophthalmology Times:  Nov 4 2009 11:37AM Matching: lumera
Helix BioPharma Corp. Announces Fiscal 2009 Results
Stockwatch:  Oct 30 2009 12:44AM Matching: lumera
The Rock-Hard Nucleus
CRS Today:  Oct 23 2009 5:36PM Matching: lumera

Lumera Corporation Patents:

US Patent No.Title
7463358 Highly stable surface plasmon resonance plates, microarrays, and methods
7067593 Poly(arylene ethers) with pendant crosslinkable groups, and devices incorporating same
7064713 Multiple element patch antenna and electrical feed network
7038004 Process for preparing poly(arylene ethers) with pendant crosslinkable groups
7019453 Polymers having pendant nonlinear optical chromophores and electro-optic devices therefrom

View more Lumera Corporation patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 359 times since April 2007, the link to the organisation's website has been followed 74 times

Recent Search Terms used to find this page: lumera and spr | lumera spr | lumera corporation | lumera corporation bothell | zeiss lumera user manual download | lumera spr | lumera 2009 website | Lumera Corporation interaction | Lumera sold SPR | lumera | .

Search for more companies in Bothell

Search for more companies in Washington



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Lumera Corporation

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.